Antimicrobial activity of vaccinium macrocarpon (cranberry) extract against bacterial strains causing urinary tract infection / Nursyafiqah Samad

• Main Author: Samad, Nursyafiqah
• Format: Thesis
• Language: English
• Published: 2019
• Subjects: Bacteria; Diseases of the genitourinary system. Urology; Fruit and fruit culture
• Online Access: https://ir.uitm.edu.my/id/eprint/51080/1/51080.pdf; https://ir.uitm.edu.my/id/eprint/51080/

Urinary tract infection (UTI) is the most common disease in the community throughout the world especially in women and it is mostly caused by gramnegative bacteria. Antibiotics are used routinely for treatment of UTIs but these agents are not always effective and can cause side effects if consumed inappropriately. Thus, many clinical studies strongly suggest the use of cranberry as the first line of defence in the prophylaxis of UTI. Cranberries have long been the focus of interest for their beneficial effects in preventing UTIs. Even though many clinical trials have been evaluating the use of cranberry products for prevention of UTIs, results have been inconsistent and the efficacy remains unknown. Therefore, the aim of this study is to determine antimicrobial activity of processed Vaccinium macrocarpon (cranberry) against bacterial strains causing urinary tract infection namely Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Filter sterilized ethanol extract of cranberry was prepared and used in this study. Antimicrobial sensitivity testing (AST) of the cranberry concentration (1000 mg/ml) was performed by using standard procedure of Kirby Bauer disc diffusion followed by minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) tests. The AST result shows that only Pseudomonas aeruginosa has shown sensitive result. E.coli and K.pneumoniae show exhibited zone of inhibition toward cranberry extract. The MIC value of cranberry extract against E.coli and K.pneumoniae are 125 mg/ml while for P.aeruginosa, cranberry extract can inhibit up until 31.25 mg/ml. The lowest MBC of E.coli and K.pneumoniae was 125 mg/ml while the lowest MBC of P.aeruginosa was at concentration of 62.5 mg/ml. In conclusion, processed cranberry has better antibacterial effect on P.aeruginosa than E.coli and K.pneumoniae in vitro. Furthermore, processed cranberry can inhibit bacteria only in small amount thus it only suitable to be consumed as prevention measure on mild UTI and not as a therapy or for chronic UTI. It is assumed that if pure cranberry extract were used, the results will be more promising.